GB9325445D0
(en)
|
1993-12-13 |
1994-02-16 |
Cortecs Ltd |
Pharmaceutical formulations
|
WO1997002815A1
(fr)
*
|
1995-07-07 |
1997-01-30 |
Nippon Kayaku Kabushiki Kaisha |
Composition de flutamide
|
US5858401A
(en)
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
CZ267796A3
(cs)
|
1996-09-12 |
1998-04-15 |
Galena A.S. |
Léčivé přípravky, zejména pro vnitřní aplikaci, ve formě samomikroemulgujících terapeutických systémů
|
US6440980B1
(en)
*
|
1996-09-17 |
2002-08-27 |
Avanir Pharmaceuticals |
Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
|
US20030105156A1
(en)
*
|
1997-01-07 |
2003-06-05 |
Nagesh Palepu |
Method for administration of a taxane/tocopherol formulation to enhance taxane therapeutic utility
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
US20030087954A1
(en)
*
|
1997-01-07 |
2003-05-08 |
Sonus Pharmaceuticals, Inc. |
Method of treating bladder carcinoma using a Taxane/Tocopherol formulation
|
US6727280B2
(en)
*
|
1997-01-07 |
2004-04-27 |
Sonus Pharmaceuticals, Inc. |
Method for treating colorectal carcinoma using a taxane/tocopherol formulation
|
GB2321455A
(en)
*
|
1997-01-24 |
1998-07-29 |
Norsk Hydro As |
Lipophilic derivatives of biologically active compounds
|
AU749301B2
(en)
*
|
1997-12-19 |
2002-06-20 |
Taro Pharmaceutical Industries Ltd. |
Topical carbamazepine formulations and methods of use
|
US20030091629A1
(en)
*
|
1998-03-27 |
2003-05-15 |
Cima Labs Inc. |
Sublingual buccal effervescent
|
US6974590B2
(en)
|
1998-03-27 |
2005-12-13 |
Cima Labs Inc. |
Sublingual buccal effervescent
|
US20030118645A1
(en)
*
|
1998-04-29 |
2003-06-26 |
Pather S. Indiran |
Pharmaceutical compositions for rectal and vaginal administration
|
JP2002513750A
(ja)
*
|
1998-05-07 |
2002-05-14 |
エラン コーポレーシヨン ピーエルシー |
溶媒/助溶剤を含まないマイクロエマルジョン及びエマルジョンプレ濃縮物のドラッグデリバリーシステム
|
AR018376A1
(es)
*
|
1998-05-26 |
2001-11-14 |
Novartis Ag |
Composiciones farmaceuticas que se pueden dispersar de una manera espontanea y el uso de las mismas para la manufactura de un medicamento
|
US7030155B2
(en)
|
1998-06-05 |
2006-04-18 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
US6174547B1
(en)
*
|
1999-07-14 |
2001-01-16 |
Alza Corporation |
Dosage form comprising liquid formulation
|
US6638522B1
(en)
*
|
1998-12-11 |
2003-10-28 |
Pharmasolutions, Inc. |
Microemulsion concentrate composition of cyclosporin
|
US7141593B1
(en)
|
1999-06-04 |
2006-11-28 |
Abbott Laboratories |
Pharmaceutical formulations
|
MXPA01012478A
(es)
*
|
1999-06-04 |
2003-10-14 |
Abbott Lab |
Formulaciones farmaceuticas mejoradas.
|
JP2003516345A
(ja)
*
|
1999-12-09 |
2003-05-13 |
アルザ・コーポレーション |
抗ウイルス剤
|
US20050037073A1
(en)
*
|
2000-01-13 |
2005-02-17 |
Alpharx Inc. |
Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof
|
GB0008785D0
(en)
*
|
2000-04-10 |
2000-05-31 |
Novartis Ag |
Organic compounds
|
WO2001080897A2
(en)
*
|
2000-04-21 |
2001-11-01 |
Vical Incorporated |
Compositions and methods for in vivo delivery of polynucleotide-based therapeutics
|
US6596306B1
(en)
*
|
2000-07-07 |
2003-07-22 |
David Ho Sue San Ho |
Drug delivery system:formulation for fat-soluble drugs
|
US6623765B1
(en)
*
|
2000-08-01 |
2003-09-23 |
University Of Florida, Research Foundation, Incorporated |
Microemulsion and micelle systems for solubilizing drugs
|
EP1333858B8
(de)
*
|
2000-11-07 |
2006-06-14 |
Immunovaccine Technologies Inc. |
Impfstoffe mit erhöhter immunantwort und verfahren zur deren herstellung
|
KR100736115B1
(ko)
*
|
2000-11-07 |
2007-07-06 |
엘지.필립스 엘시디 주식회사 |
액정 광학필름
|
US6919370B2
(en)
*
|
2000-11-28 |
2005-07-19 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
|
AU2002240206B2
(en)
*
|
2001-02-01 |
2006-07-27 |
Supernus Pharmaceuticals, Inc. |
Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle
|
US10004684B2
(en)
|
2001-02-14 |
2018-06-26 |
Gw Pharma Limited |
Pharmaceutical formulations
|
US6730330B2
(en)
|
2001-02-14 |
2004-05-04 |
Gw Pharma Limited |
Pharmaceutical formulations
|
WO2002064109A2
(en)
*
|
2001-02-14 |
2002-08-22 |
Gw Pharma Limited |
Mucoadhesive pharmaceutical formulations
|
FR2828102B1
(fr)
*
|
2001-03-28 |
2004-07-09 |
Ifc Sa |
Utilisation des lipoaminoacides dans une composition pharmaceutique comme promoteur et systeme disperse a usage pharmaceutique contenant de tels composes
|
WO2002087621A1
(en)
*
|
2001-04-30 |
2002-11-07 |
Shire Laboratories Inc. |
Pharmaceutical composition including ace/nep inhibitors and bioavailability enhancers
|
US20030068356A1
(en)
*
|
2001-07-10 |
2003-04-10 |
Pather S. Indiran |
Sequential drug delivery systems
|
US7237679B1
(en)
|
2001-09-04 |
2007-07-03 |
Aveka, Inc. |
Process for sizing particles and producing particles separated into size distributions
|
KR100978836B1
(ko)
*
|
2001-10-19 |
2010-08-30 |
이소테크니카 인코포레이티드 |
신규한 시클로스포린 유사체 미세유화액 예비농축물
|
US6602911B2
(en)
|
2001-11-05 |
2003-08-05 |
Cypress Bioscience, Inc. |
Methods of treating fibromyalgia
|
US6635675B2
(en)
|
2001-11-05 |
2003-10-21 |
Cypress Bioscience, Inc. |
Method of treating chronic fatigue syndrome
|
WO2003045357A1
(en)
*
|
2001-11-27 |
2003-06-05 |
Transform Pharmaceuticals, Inc. |
Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
|
US20030191093A1
(en)
*
|
2001-12-03 |
2003-10-09 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
FR2834215B1
(fr)
*
|
2001-12-27 |
2004-07-16 |
Physica |
Composes amphiphiles a usage pharmaceutique ou cosmetique
|
EP1549299B1
(de)
*
|
2002-06-05 |
2014-08-20 |
IVAX Pharmaceuticals s.r.o. |
Verringerung der gelatine-vernetzung
|
GB0217056D0
(en)
*
|
2002-07-23 |
2002-08-28 |
Ass Octel |
Use
|
US20040087564A1
(en)
*
|
2002-10-31 |
2004-05-06 |
Wright D. Craig |
Delivery composition and method
|
US20050026877A1
(en)
*
|
2002-12-03 |
2005-02-03 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
AU2003900887A0
(en)
*
|
2003-02-27 |
2003-03-13 |
Novasel Australia Pty Ltd |
Poloxamer emulsion preparations
|
US8802116B2
(en)
|
2003-02-27 |
2014-08-12 |
Novasel Australia Pty. Ltd. |
Poloxamer emulsion preparations
|
US20050020546A1
(en)
*
|
2003-06-11 |
2005-01-27 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
US8211448B2
(en)
*
|
2003-07-07 |
2012-07-03 |
Nares Ab |
Microemulsions and its use for preventing airway diseases
|
DE602004018161D1
(de)
*
|
2003-07-28 |
2009-01-15 |
Mallinckrodt Inc |
Verbesserte stearat-zusammensetzung und herstellungsverfahren dafür
|
US20050074469A1
(en)
*
|
2003-10-03 |
2005-04-07 |
Charles Signorino |
Stable lipophilic emulsions for acrylic coating and method of making
|
WO2005053727A2
(en)
*
|
2003-11-29 |
2005-06-16 |
Sangstat Medical Corporation |
Pharmaceutical compositions for bioactive peptide agents
|
WO2005053651A1
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Multiparticulate compositions with improved stability
|
WO2005053652A1
(en)
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
|
WO2005053656A1
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
|
US6984403B2
(en)
*
|
2003-12-04 |
2006-01-10 |
Pfizer Inc. |
Azithromycin dosage forms with reduced side effects
|
RU2006119453A
(ru)
*
|
2003-12-04 |
2007-12-20 |
Пфайзер Продактс Инк. (Us) |
Получение посредством основанных на применении жидкостей способов лекарственные формы азитромицина с большим количеством частиц
|
WO2005053639A2
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Controlled release multiparticulates formed with dissolution enhancers
|
WO2005053655A1
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Method for making pharmaceutical multiparticulates
|
CA2547773A1
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride
|
PE20050596A1
(es)
*
|
2003-12-19 |
2005-10-18 |
Novartis Ag |
Microemulsion que comprende un inhibidor renina
|
NZ548216A
(en)
*
|
2003-12-31 |
2010-02-26 |
Cima Labs Inc |
Generally linear effervescent oral fentanyl dosage form and methods of administering
|
US7862833B2
(en)
*
|
2003-12-31 |
2011-01-04 |
Cima Labs, Inc. |
Effervescent oral opiate dosage forms and methods of administering opiates
|
WO2005065317A2
(en)
|
2003-12-31 |
2005-07-21 |
Cima Labs Inc. |
Effervescent oral fentanyl dosage form
|
GB2411355B
(en)
*
|
2004-02-27 |
2006-02-22 |
Niche Generics Ltd |
Pharmaceutical composition
|
US20050232974A1
(en)
*
|
2004-04-19 |
2005-10-20 |
Gore Makarand P |
System and a method for pharmaceutical dosage preparation using jettable microemulsions
|
US20050282756A1
(en)
*
|
2004-06-18 |
2005-12-22 |
Mehta Nozer M |
Oral delivery of peptide pharmaceutical compositions
|
WO2006048895A1
(en)
*
|
2004-11-08 |
2006-05-11 |
Rubicon Research Pvt. Ltd. |
Aqueous pharmaceutical coating
|
WO2006061827A1
(en)
*
|
2004-12-06 |
2006-06-15 |
Nutralease Ltd. |
Microemulsion comprising carbamazepine having solubility
|
JP2006232755A
(ja)
*
|
2005-02-25 |
2006-09-07 |
Dai Ichi Kogyo Seiyaku Co Ltd |
油中水型マイクロエマルション
|
US20060240108A1
(en)
*
|
2005-04-26 |
2006-10-26 |
Bernard Bobby L |
Cellulosic films incorporating a pharmaceutically acceptable plasticizer with enhanced wettability
|
US8851294B2
(en)
|
2005-05-25 |
2014-10-07 |
W. L. Gore & Associates, Inc. |
Aqueous delivery system for low surface energy structures
|
US7994220B2
(en)
*
|
2005-09-28 |
2011-08-09 |
Cypress Bioscience, Inc. |
Milnacipran for the long-term treatment of fibromyalgia syndrome
|
US20070104741A1
(en)
*
|
2005-11-07 |
2007-05-10 |
Murty Pharmaceuticals, Inc. |
Delivery of tetrahydrocannabinol
|
US8440695B2
(en)
*
|
2005-11-09 |
2013-05-14 |
St Jude Children's Research Hospital |
Use of chloroquine to treat metabolic syndrome
|
US8124598B2
(en)
*
|
2006-09-14 |
2012-02-28 |
Sharon Sageman |
7-keto DHEA for psychiatric use
|
US20090060993A1
(en)
*
|
2007-09-04 |
2009-03-05 |
Joseph Schwarz |
Solid pharmaceutical composition for enhanced delivery of coenzyme q-10 and ubiquinones
|
US20100160274A1
(en)
*
|
2007-09-07 |
2010-06-24 |
Sharon Sageman |
7-KETO DHEA for Psychiatric Use
|
US20090123537A1
(en)
*
|
2007-11-12 |
2009-05-14 |
Debrouse Daniel R |
Oral dosage form of ceftriaxone and methods of use
|
US20100004345A1
(en)
*
|
2008-07-01 |
2010-01-07 |
Signorino Charles A |
High gloss non-stick film coating compositions
|
EP2331088A4
(de)
|
2008-08-06 |
2011-10-12 |
Gosforth Ct Holdings Pty Ltd |
Zusammensetzungen und verfahren zur behandlung von psychiatrischen erkrankungen
|
MX2011006307A
(es)
*
|
2008-12-15 |
2011-10-14 |
Banner Pharmacaps Inc |
Metodos para aumentar la liberacion y absorcion de agentes activos insolubles en agua.
|
EP2378868A2
(de)
*
|
2008-12-18 |
2011-10-26 |
Basf Se |
Wässrige dispersion umfassend pestizidpartikel und amphiphil
|
WO2010102198A1
(en)
*
|
2009-03-06 |
2010-09-10 |
Tamarisk Technologies, L.L.C. |
Microencapsulated bioactive agents for oral delivery and methods of use thereof
|
WO2010114770A1
(en)
*
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
WO2010114768A1
(en)
*
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-epothilone conjugates, particles, compositions, and related methods of use
|
CA2756072A1
(en)
*
|
2009-03-30 |
2010-10-14 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
EP2301523A1
(de)
*
|
2009-09-22 |
2011-03-30 |
Dr. August Wolff GmbH & Co. KG Arzneimittel |
Galenische Formulierung in kolloidaler Form
|
CN101756900B
(zh)
*
|
2010-02-25 |
2012-05-30 |
谢恬 |
一种榄香烯微乳
|
GB201111712D0
(en)
|
2011-07-08 |
2011-08-24 |
Gosforth Ct Holdings Pty Ltd |
Pharmaceutical compositions
|
EA037797B1
(ru)
|
2011-10-25 |
2021-05-21 |
Протена Байосайенсиз Лимитед |
Состав антитела, пригодный для профилактики и лечения амилоидоза, его варианты и способ его получения
|
KR102237799B1
(ko)
|
2012-11-14 |
2021-04-08 |
더블유.알. 그레이스 앤드 캄파니-콘. |
생물학적 활성 물질 및 비-정렬된 무기 산화물을 함유하는 조성물
|
ES2498521B1
(es)
*
|
2013-02-20 |
2015-08-18 |
Fundación Pública Andaluza Para La Investigación De Málaga En Biomedicina Y Salud (Fimabis) |
Formulaciones basadas en nanoemulsiones y su uso para el tratamiento de la obesidad
|
KR101793806B1
(ko)
|
2013-03-15 |
2017-11-03 |
더블유.엘. 고어 앤드 어소시에이트스, 인코포레이티드 |
저 표면 에너지 구조를 위한 수성 전달 시스템
|
US9616025B2
(en)
|
2013-10-29 |
2017-04-11 |
Echo Pharmaceuticals B.V. |
Compressed tablet containing Δ9-tetrahydrocannabinol, method for its manufacture and use of such tablet in oral treatment
|
US20150133516A1
(en)
|
2013-11-13 |
2015-05-14 |
Brian K. Adams |
Methods and Compositions for Treating ADHD
|
EP2878311A1
(de)
|
2013-11-27 |
2015-06-03 |
Freund Pharmatec Ltd. |
Verbesserung der Löslichkeit für hydrophobe Wirkstoffe
|
AU2016288643A1
(en)
|
2015-07-02 |
2018-02-22 |
University Of Louisville Research Foundation, Inc. |
Edible plant-derived microvesicle compositions for delivery of miRNA and methods for treatment of cancer
|
AU2018221739A1
(en)
*
|
2017-02-15 |
2019-08-29 |
Molecular Infusions, Llc |
Formulations
|
EP3424493A1
(de)
*
|
2017-07-07 |
2019-01-09 |
SolMic Research GmbH |
Stabile cannabinoide zusammensetzungen
|
BR102020010237A2
(pt)
*
|
2020-05-22 |
2021-12-07 |
Ouro Fino Saúde Animal Ltda |
Plataforma para mascaramento de sabor
|